The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

The presence of another immune-mediated disease in IBD patients was associated with higher likelihood of pancolonic involvement in UC, and a modest increase in need for IBD-related surgery and anti-TNF biological therapy. Such patients also experienced worse quality of life.